Find the Right Companion Diagnostic

Vysis ALK Break Apart FISH Probe Kit is an FDA-approved, dual-color fluorescence in situ hybridization assay that uses break-apart DNA probes targeting the ALK locus in FFPE non–small cell lung cancer tissue. By detecting split or isolated ALK signals, it identifies ALK gene rearrangements and classifies tumors as ALK positive or negative to guide ALK-directed treatment strategies.

Quest Diagnostics AAVrh74 Antibody ELISA CDx is a prescription-use, ELISA-based companion diagnostic that qualitatively detects antibodies to the AAVrh74 capsid in human serum. By determining AAVrh74 antibody status before treatment, it helps identify patients who are seronegative or below a defined titer threshold and may be eligible for AAVrh74 vector–based gene therapy.

Oncomine Dx Target Test is an FDA-approved, qualitative targeted NGS assay performed on the Ion PGM Dx System. Using DNA and RNA from FFPE tumor tissue, it detects single-nucleotide variants, insertions, deletions, and fusions in a defined panel of cancer driver genes. It is approved for use in NSCLC and several other solid tumors to characterize oncogenic alterations and support selection of targeted treatment strategies.